incidence of TTI would be more .In spite of technological advancements, the problems of 'window period', falsenegative results, prevalence of asymptomatic carriers, genetic variability in viral strains and technical errors to be considered. 1 Hepatitis B is one of the common TTI. In most of the blood banks the diagnosis of HBV infection is based on the presence of Hepatitis B Surface Antigen in the Blood stream which does not confirm the absence of HBV infection. The occult HBV infection can only be diagnosed by HBc and HBV DNA. Many workers had shown a significant numbers of HBsAg negative blood donors were anti HBc positive and exposed to HBV infection. These donors are potential for transmitting HBV contaminated blood. Some literatures showed 0.81% HIV Positivity 4 and presence of co-infection TTI among blood donors. Currently safe blood transfusion is ensured by careful donor's selection and mandatory screening for TTI. In spite of all precautions, transmission of HIV via blood and components transfusion is still present. This is mostly due to collection of blood during window phase .
5
There are many studies on the prevalence of TTI in blood donors. [6] [7] [8] Less number of data showed presence of coinfection with more than one TTI. [6] [7] [8] [9] In the present study we analyzed the patterns of infections among the blood donors and the recipients including multireceipients (thalassaemia), in a rural medical college and hospital blood bank in our region covering about average distance of 30 km around the centre over a period of 6 years. TTI continue to be problems in many part of the world as well India and the multitransfused patients of Thalassaemia major are particularly at increased risk of TTI. 10 The aim of this study was to find out the incidence of seropositivity of TTI among the blood donors (voluntary + replacement) and increase the number of donors for safe blood.
Methods:
The present study was conducted at the Department Out of total donors only 13 female (0.01%) were seroreactive and none had co infection.
The age incidence of seropositive donors ranged from 19 to 50 years where as about 80% donors with co infection were 26 to 33 years.
Out of total 127995 collected blood 1645(1.28%) blood were discarded, of which 1463(88.94%) were due to seropositivity and 182(11.06%) were due to other causes include hemolysis, less collection , damage to the bags during transportation and date expiry etc.126350 units of blood were issued for transfusion. 9 multitransfused recipients were found seropositive and 7 of them were Thalssaemic. All of them were seronegaive before transfusion.
The incidence of co infection reduced dramatically from 2009. No donors were detected with co-infection in 2010& 2011.
Discussion:
In spite of screening, TTIs continue to be burden to safe blood transfusion practices. With every unit of blood, there is 1% chance of a transfusion related problem including TTIs.
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Professional donors and donors with high risk behavior such as drug addict, homosexual, commercial sex workers carry more risk of TTI positivity.
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Transfusion of blood & blood components are life saving measures of innumerable of patients worldwide. On the contrary blood and blood components are one the important route for transmission of TTI. In developing country absolute safe transfusion is far away which need awareness, education and improved technology for attaining zero level of Transfusion acquired infection. In the present study 1463 donors were sero reactive showing a gradual tendency of declining seroreactivity (Chart-II).The co infection is statistically higher in replacement donors (p < 0.001) though the rate of co infection is less in our country. Gangadeep Kaur et al (2010) showed co infection is higher in replacement donors than voluntary donors (P < 0.005) and similar to other studies (Table -4) . Our study showed 66.66% co infection with HBsAg and 63.33% with HIV and 50% had VDRL co infection. Most common co infection was HIV& HBsAg (23.33%) followed by HIV& VDRL (20%) and HBsAg& VDRL (20%) and 93.33% donors had co infection either with HBsAg or HIV.
Post transfusion infections occurred in 9 recipients (0.007%) and mostly were Thalssaemic (77.77%) and all were multitransfused. The TTI from screened blood depends on various factors like the safety of donor population, sensitivity of the screening tests used & numbers of test performed window-period donations, and other reasons such as mutant strains.
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Roopam Jain et al in their study showed that out of 96 multitransfused Thalssaemic patients, 24 (25%) were reactive for anti-HCV. The seroreactivity of males were significantly higher than females (p < 0.0001) No female donor showed co infection.
India has one of the largest pools of hepatitis B-infected patients 12, 13 and of all seroreactive donors HBV is more common (0.8%) .
Chronic hepatitis B virus (HBV) infection remains a major public health problem worldwide with more than 300 million chronic carriers. 14 The course of HBV infection depends on several factors that can influence the immune system, including age at infection and host genetic factors, and genetic variability of the virus influencing the expression of the viral antigens. 18 Proper screening of HBV can be done to prevent transfusion-transmitted hepatitis B virus (HBV) by using progressively more sensitive HBsAg assays.
Nucleic acid amplification testing (NAT) for HCV and HIV infection had been successfully introduced to screen donors in many developed countries but the cost-effective ness to be considered in our country.
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HIV reactor among blood donors in the present study was 0.10% and had co infection 63.33%. According to the action plan of NACO all the HIV reactive blood donors should be notified of their status. In the developing countries like India confirmatory tests using Nucleic acid amplification technique (NAT) on HIV seroreactive blood is not feasible.
In India seroprevalance of HCV varies 0.12-4 % 21 which varies geographically.
Based on the results we feel that to reduce the risk of these infections blood should be accepted from voluntary donors & repeat voluntary donor. Donor selection and screening procedures must be strictly followed for the blood safety.
Voluntary blood donation has to be made a part of healthy lifestyle, proper health education to be given to public about the benefits of voluntary blood donation & proper assurance to be given to all donors regarding the life style.
Conclusion:
To wipe of scarcity of blood and ensure availability of safe quality blood & component round the clock and throughout the year the transfusion service must necessarily be supported by voluntary blood donors.
Consequently, the recruitment of voluntary donors becomes one the most important aspects of blood transfusion services. Thus, healthy, responsive and motivated voluntary blood donors are the back-bone of the transfusion service.
Blood is a life saving agent but blood transfusion can be responsible of life threatening infections to the recipient if pre transfusion screening tests are not done properly.
Presently the safety of blood for transfusion is maintained by careful selection of voluntary donors and performing the mandatory screening for transfusion transmissible infections (TTI) as meticulously as possible.
